INTRODUCTION 0 suggesting different stopping points for treatment non-response in genotypes A-D (6). 7 1
Evidence increasingly supports a role for HBV genotype in influencing disease progression 7 2
including risk of developing chronic infection, e-antigen seroconversion, transmission mode, 7 3 and the development of hepatocellular carcinoma (7, 8) . Studies often refer to 'wild-type' 7 4
virus (8, 9) , but 'wild-type' for one genotype may not reflect consensus for other genotypes 7 5
(10,11). Understanding the diverse range of HBV strains circulating globally, and their 7 6
associations with disease will allow us to move towards a more specific and precise 7 7 approach to analysis. 7 8 7 9
A consistent approach to HBV subtyping is increasingly relevant, as interest in studying the 8 0 associations between disease outcomes and viral sequence expands, and deep sequencing 8 1 is used to investigate viral diversity in increasingly larger cohorts. A progressive body of 8 2 sequencing data is emerging, and this expansion of available data is likely to increase over 8 3 time (Suppl. Fig 1) ; however, the number of sequences covering the full genome lag a long 8 4 way behind sequences for single genes or shorter fragments. To date, numerous subtyping 8 5
misclassifications have been documented for HBV, predominantly driven by the use of 8 6 partial genome sequences rather than full-length genomes (9,10), the inappropriate 8 7
classification of recombinant strains (11), and publications re-designating same subgenotype 8 8
classifications to distinctly different strains (12, 13) . Whilst a number of HBV sequence and 8 9
analysis resources already exist, including HBVdb (14), HBVRegDB (15), HBVDR (16) and 9 0 geno2pheno (https://hbv.geno2pheno.org/), each defines different sets of reference 9 1 sequences, and frequently only at the genotype level. Despite proposed criteria for defining 9 2
HBV genotypes and subgenotypes (3), currently there is no single resource where all the 9 3 necessary sequences and their designation is readily available for use. 9 4 9 5
With this dataset, we have set out to provide a unified resource, taking a pragmatic approach 9 6
to describing the phylogeny of HBV genotypes A-I using all available genotyped sequences 9 7
from the HBVdb repository (14) . We removed highly similar sequences from downloaded 9 8
alignments and performed maximum-likelihood phylogenetic analysis. We used the 9 9
phylogeny of whole genome sequences to identify well-supported clades and selected 1 0 0
representative reference sequences for each identifiable subgenotype. 1 0 1
Generation of a dataset of genomic-length HBV sequences 1 0 4
We downloaded a total of 7108 full length HBV sequences from the hepatitis B virus 1 0 5 database (HBVdb, https://hbvdb.ibcp.fr/HBVdb/) on 31st of January 2019. Following clean-1 0 6
up of the dataset to remove identical sequences and recombinants (as described in detail in 1 0 7
the methods section) we were left with a total of 5972 sequences. We aligned the sequences 1 0 8
using MAFFT and calculated pairwise distances for hierarchical clustering, which was then 1 0 9
used to remove highly similar isolates (see methods). At this stage we were left with 2839 1 1 0 sequences on which we based our phylogenetic analysis (all sequences shown in Fig. 1 ). 1 1 1 1 1 2
Classification of HBV genotypes, subgenotypes and designation of references 1 1 3
We selected appropriate reference sequences to represent each genotype and subgenotype 1 1 4 groups; these sequences are shown in the context of the overall phylogeny highlighted in 1 1 5
Figures 2-9 and listed in Table 1 . In cases where we could identify multiple distinct clades 1 1 6 within a single subgenotype (subgenotypes A1, B2, C2, D1; Figs 2-5), we selected a 1 1 7 reference for each clade to ensure the diversity within the subgenotype was represented. In 1 1 8
genotypes A-D, the most well-represented subgenotypes contained ≥ 45% of all the 1 1 9
sequences within that genotype. Sequences were most evenly distributed between 1 2 0 subgenotypes in genotype F, with the commonest subgenotype accounting for 33% of 1 2 1 sequences. 1 2 2 1 2 3
Ambiguities and inconsistencies in existing data 1 2 4
There are a number of poorly characterised and disputed subgenotypes in the literature, 1 2 5
particularly within genotype C, making accurate identification of the subgenotypes 1 2 6
challenging. Strong evidence to support a number of previously described clades was also 1 2 7 difficult to ascertain, with specific difficulties in assessment of certain subgenotypes; D6, C7 1 2 8
and C9 were not easily distinguishable in this analysis. A search of Genbank indicated a 1 2 9 single genomic-length sequence of subgenotypes A4 (KM606737), A6 (GQ331046), and D6 1 3 0 (KF170740) in the database, and no evidence of genomic-length sequences for 1 3 1 subgenotype C7 or C9 isolates. Both A4 and A6 isolates clustered away from other 1 3 2 sequences in the analysis, but few additional isolates of the subgenotypes were retained 1 3 3 after removing highly similar sequences. In the case of subgenotype C7, previous 1 3 4
publications on the phylogeny of genotype C used EU670263 as a C7 reference strain 1 3 5
(17,18). However, in Genbank, EU670263 is listed as subgenotype C6 (19), and clusters 1 3 6
within our phylogenetic analysis with GU721029, which is also designated subgenotype C6. 1 3 7
A single provisional isolate of subgenotype C9 exists (AP011108), having been proposed by 1 3 8
Mulyanto et al. in 2010 (17) but this designation is not present in the Genbank data 1 3 9
associated with the sequence. Likewise, subgenotypes C13-C16 have been described (20), 1 4 0 but we were unable to distinguish these as distinct subgenotypes in our analysis. The D6 1 4 1 isolate KF170740 was not retained in the sequences we selected for analysis, suggesting it 1 4 2
is closely related to another genotype D subgenotype. 1 4 3 1 4 4
Comparative phylogenies and pairwise distance of HBV genotypes 1 4 5
We aligned our newly defined genotype and subgenotype reference sequences, and used 1 4 6 these to generate a ML phylogenetic tree ( Fig 10) . Pairwise distance analysis for the majority 1 4 7 of genotypes ( Fig 11) revealed a bi-modal distribution of the distances, with one peak 1 4 8
representing the relationship to sequences from the same (or closely related) clades 1 4 9
(typically showing 1-3% divergence) and the other peak being characteristic of distance to 1 5 0 sequences in other clades from other subgenotypes (typically 3-8% divergence). Genotype 1 5 1 D differed from this distribution with a single peak where the majority of pairwise distances 1 5 2
were between 2-4%. This indicates that genotype D phylogeny does not contain long 1 5 3 evolutionary branches separating clades from each other. Genotypes E, F, H and I 1 5 4
contained smaller number of sequences, which can impact the pairwise distances 1 5 5
distribution. In this group genotypes E, H and I showed a uni-modal distribution of the 1 5 6 pairwise distances. The lowest pairwise divergence was observed in genotype H, where the 1 5 7 majority of pairwise distances were <3%. Genotype F demonstrated the greatest between-1 5 8
sequence diversity, where a high proportion of pairwise distances were >5%, likely a 1 5 9
reflection of the long evolutionary distance between subgenotypes. Genotype G had only 1 6 0 three sequences after our initial filtering which was too small for a meaningful pairwise 1 6 1 distance analysis. Summary of this resource 1 6 8
We have collated genomic-length HBV reference sequences into a repository, generating a 1 6 9
resource that will help to underpin research. As clinical practice evolves to incorporate 1 7 0 recommendations pertaining to HBV genotype, our dataset will also potentially become 1 7 1 useful to support sequence-based insights for clinical practice. 1 7 2 1 7 3
Insights into diversity and geography 1 7 4
Genotype C has a particularly extensive phylogeny relative to the other genotypes. 1 7 5
Genotype C is prevalent in the Asia-Pacific region and is thought to be the oldest extant 1 7 6 genotype (21). The expansive diversity within this genotype is likely a consequence of its 1 7 7 long evolutionary history in humans, although it should be noted that this genotype is also 1 7 8
the most well represented genotype in the analysis, accounting for over 1/3 of all sequences 1 7 9
in our dataset. Considerable diversity is also observed with genotypes B and D. Genotype D 1 8 0 has a relatively broad geographic prevalence, being found in regions including the 1 8 1
Mediterranean, North-Eastern Europe, India, Oceania and parts of southern Africa (22). It is 1 8 2 possible that persistence of chronic HBV infection in these varied ethnic groups has 1 8 3
contributed to the diversification of this genotype. 1 8 4 1 8 5
Genotype F has an atypical phylogeny compared to other genotypes, comprising four 1 8 6
subgenotypes separated by long evolutionary distances, but with little intra-subgenotype 1 8 7
diversity. It is unclear if the unusual phylogeny is a result of the elevated substitution rate 1 8 8
documented for genotype F (23) or if there is a paucity of sampling relative to the other 1 8 9
genotypes. The genotype is distributed throughout Latin America and the Arctic Circle 1 9 0 (24,25), regions that are under-represented by clinical and research cohorts to date. 1 9 1
Genotypes E, G and H, each of which has a single subgenotype, have relatively constrained 1 9 2 phylogenies, showing low levels of genetic diversity in the currently sampled isolates. 1 9 3
Genotype G has a particularly low evolutionary rate, likely resulting from the 36bp insertion 1 9 4
in the core gene hampering viral replication (26). The genotype is typically observed in co-1 9 5 infection with either HIV or HBV genotype A2 (26). 1 9 6 1 9 7
A HBV strain isolated from a 16 th century skeleton (LT992440) clustered between 1 9 8
subgenotypes in genotype A. The isolate falls (with long branch lengths) together with two 1 9 9
sequences both isolated from patients in Belgium, one of which has been proposed as the 2 0 0 hypothetical subgenotype A6 (GQ331046), isolated in 2006 (27) . The clustering of these 2 0 1 three sequences highlights the protracted association of HBV with human populations, and 2 0 2 the marked lack of temporal population structure displayed by the viruses, frequently 2 0 3
confounding phylogenetic attempts to understand the evolutionary history of HBV (28,29). 2 0 4 2 0 5
Limitations 2 0 6 (i) Errors and inconsistencies in existing classification system 2 0 7
There are a number of poorly characterised and disputed HBV subgenotypes in the 2 0 8 literature, particularly within genotype C. A cause of these inconsistencies is the assigning of 2 0 9
'provisional' subgenotypes, based on a single isolate, as is the case with C7 and C9. Using 2 1 0
the published literature to inform our analysis, we took an indication of strong bootstrap 2 1 1 support, and a threshold of ≥ 2 sequences to define and identify the subgenotype clades. For 2 1 2 some subgenotypes, including A4 and A6, multiple isolates have been reported in the 2 1 3 literature but few isolates were retained in our analysis after removing highly similar 2 1 4
sequences, suggesting divergence within the subgenotype is limited. Despite this approach, 2 1 5 a number of clades grouped distinctly away from known subgenotypes but could not be 2 1 6
categorically assigned to a subgenotype (thus we designated two 'unidentified clades' in 2 1 7 genotype C). 2 1 8 2 1 9
We suggest that, in future, a minimum number of epidemiologically unlinked sequences and 2 2 0 genomic coverage (e.g.
≥ 2 genomic-length unlinked sequences) should be required to 2 2 1 designate a new HBV subgenotype. Bias introduced into databases from intra-host diversity 2 2 2 studies, where multiple sequences are isolated from the same patient (such as clonal 2 2 3 analysis) can confound such analyses, but should have been largely controlled for in this 2 2 4 case by stripping the alignments of similar sequences. 2 2 5 2 2 6
The phylogenetic methods selected may affect the subgenotypes classified, as there may be 2 2 7 variability in bootstrap support between methods. Both neighbour-joining and parsimony 2 2 8 methods are considered less accurate than maximum-likelihood approaches (30,31), as 2 2 9
used in this study. Future analysis to define HBV subgenotypes should be based on 2 3 0 maximum-likelihood methods and the bootstrap support should be indicated.
There is considerable variation in the numbers of sequences available for each genotype, 2 3 4
with genotypes B and C particularly well represented and genotypes E-I relatively neglected. 2 3 5
Whilst these differences may reflect genuine variation in the contribution of different 2 3 6
genotypes to the total global pool of infection -with B and C coming from high-prevalence, 2 3 7 densely populated regions -significant under-sampling of HBV sequences from other 2 3 8
regions is likely (especially from low-income regions). Similar trends in isolate bias have 2 3 9
been reported in the HCV field (32). Consequently, the sequences available in publicly 2 4 0 available databases are likely to under-represent the true extent of HBV diversity and, as 2 4 1 more sequences are generated reference sets will need to be reviewed. Several previous studies publishing HBV reference sequence sets have generated 2 4 4
consensus sequences from alignments of full genome HBV sequences and submitted these 2 4 5
new consensus sequences to Genbank (33, 34) , which leads to the potential inference that 2 4 6
these are sequences of biological origin. A number of genotype B, D and F sequences 2 4 7 generated with the same approach have also been submitted to Genbank but they are not 2 4 8
supported by an associated publication, making it impossible to assess their provenance. 2 4 9
The methods used to generate these sequences mean that, by definition, they occupy a 2 5 0 basal position in the subgenotype clades after phylogenetic analysis and appear to be ideal 2 5 1 reference sequences. However, these consensus sequences may differ from biologically 2 5 2 derived sequences at key sites, and are therefore potentially misleading if used as reference 2 5 3
sequences. Improved sequence metadata in the records of published sequences, clearly 2 5 4
indicating the methods used to derive these sequences would be informative for 2 5 5
researchers. 2 5 6 2 5 7 (iii) Recombination and 'quasi-subgenotypes' 2 5 8
Recombination is relatively common amongst HBV isolates (11, 35 ) and a number of 2 5 9 established HBV subgenotypes have been shown to have a recombinant origin, particularly 2 6 0 in genotypes A, C, D and the putative genotype J (35-37). A number of sequences in our 2 6 1 phylogenetic analysis were not easily classified, as they fall phylogenetically between two 2 6 2 well-defined subgenotype clades. These sequences are possibly inter-subgenotype 2 6 3 recombinants, combining genetic regions from two or more subgenotypes, making them 2 6 4 challenging to classify in genomic-length genome phylogenies. 2 6 5 2 6 6
Previous work has indicated that some designated subgenotypes, including A3, A4, A5, C2 2 6 7
and B3 group as distinct, monophyletic clades in maximum-likelihood analysis but that they 2 6 8
do not meet the required genetic distance to be classified as separate subgenotypes 2 6 9
( 3, 9, 38) . It has been suggested these should instead be designated 'quasi-subgenotypes' to 2 7 0 reflect their divergent nature but underscore that they do not meet the technical definition of 2 7 1 a subgenotype (9). In our analysis, quasi-subgenotype A3 grouped into A3, A4 and A5 2 7 2 clades with strong bootstrap support. It was not possible to separate subgenotypes C2 and 2 7 3
quasi-B3 (encompasses B3 and B5) into distinct subgenotypes. Sequencing is increasingly utilised in the clinical management of HBV infection to inform on 2 7 7 prognosis, treatment choice, drug resistance and to provide insight into complex cases 2 7 8 (39, 40) . Whilst progress in applying new sequencing technologies to HBV has been slow to 2 7 9 date, we are now entering an era of rapid change. A consistent, unified approach to 2 8 0 classification will advance this field, improving consistency of curating, archiving and 2 8 1
reporting sequence data. Recent work sampling poorly accessed populations has uncovered 2 8 2 numerous new HCV isolates (41, 42) , and the diversity of sequences generated for HBV may 2 8 3 expand in a similar way. The use of a robust and consistent classification system will also be 2 8 4
important in screening new populations for potentially novel HBV isolates. All of the 2 8 5 generated data, including the alignments, phylogenies, consensus sequences and chosen 2 8 6
reference sequences are available online as a simple and open-access resource 2 8 7
(https://doi.org/10.6084/m9.figshare.8851946). We have generated a new data resource for 2 8 8
researchers and clinicians in the HBV field, providing a solid foundation for analysis, and a 2 8 9
structure on which to build as more data emerge. 2 9 0 2 9 1 METHODS 2 9 2 Definitions 2 9 3
We based our analysis on previously agreed definitions regarding classification of HBV 2 9 4
sequences on the basis of their nucleotide sequence diversity (3), as follows: 2 9 5
• Genotype: nucleotide divergence of >7.5% has been proposed as the threshold for 2 9 6
the definition of distinct HBV genotypes (43). 2 9 7
• Subgenotype: Genotypes are further classified into subgenotypes, based on a 2 9 8 divergence of 4-7.5%, monophyletic clustering, and strong bootstrap support for the 2 9 9 clade (3). 3 0 0 3 0 1
In this study, we used strong bootstrap support (≥70) and monophyletic clustering to identify 3 0 2 distinct clades and examined the pre-existing literature for the likely subgenotype 3 0 3 designation. In instances when subgenotypes can be seen to split into distinct clades but 3 0 4
genetic distance and poor bootstrap support do not suggest a unique subgenotype, such as 3 0 5
in the case of subgenotypes A1 (Fig 2) and C2 (Fig 4) , we have referred to these as 'A1 (1)' 3 0 6
and 'A1 (2)'. 3 0 7 3 0 8 HBV genome numbering convention 3 0 9
As HBV is a circular virus, there is technically no 'start' or 'end' to the genome. We have 3 1 0 followed convention in the field (and HBVdb) for this study, defining nucleotide (nt)1 at an 3 1 1
EcoR1 restriction site in the Pol/Surface overlap (GAA/TTC, with nt1 starting at the first T) 3 1 2
(2). The EcoR1 site is hypothetical in many HBV sequences, with GAA/CTC being more 3 1 3 frequent in many genotypes. 3 1 4
3 1 5
Sources of sequence data 3 1 6
We downloaded all available genomic-length genotyped HBV sequences (N=7108) for 3 1 7
genotypes A-H from HBVdb (14) on 31st of January 2019, and removed sequences 3 1 8
indicated as recombinant by the database (N=767), giving a total of 6341 sequences. We 3 1 9
used HBVdb as the database runs sequences downloaded from Genbank through a 3 2 0
genotyping algorithm prior to inclusion and all listed sequences are annotated to ensure they 3 2 1 follow the HBV genome numbering (14), as outlined above. 3 2 2 3 2 3
We enhanced our dataset by excluding two sequences from the genotype G phylogeny, as 3 2 4
they had been incorrectly genotyped with the HBVdb algorithm. Both sequences (FJ023674 3 2 5
and FR714503) were found to be partial genotype C recombinants. We also identified an 3 2 6
additional 71 sequences belonging to genotype I and to genotype C and D subgenotypes 3 2 7
(under-represented in the HBVdb database) on Genbank and added these to our data set, 3 2 8
giving a total of 6412 sequences. Ancient HBV sequences, isolated from bodies hundreds of 3 2 9
years old (28,44), are present in these databases and they were not excluded from this 3 3 0 analysis, unless they grouped distantly from a known genotype .  3  3  1   3  3  2 Existing reference sequences 3 3 3
We included the genotype A strain X02763 (45) in the alignment with other reference 3 3 4 sequences as this sequence (length 3221bp) is widely used as a numbering reference. Only 3 3 5
Geno-G has insertions relative to genotype A. We suggest that the current NCBI HBV 3 3 6
Reference Sequence, NC_003977.2 (46), a genotype D isolate, is less suitable as a 3 3 7
numbering reference as genotype D strains have a 33-bp deletion in pre-S1, making them 3 3 8
the shortest length HBV genotype at 3182bp. Nonetheless, we also included NC_003977.2 3 3 9
in the reference alignment as it is frequently used as a reference. We aligned all sequences using MAFFT (47) and calculated pairwise distances between all 3 4 3
isolates. In order to reduce the possibility that multiple sequences from a single individual or 3 4 4 closely related cluster could dominate the phylogeny, we kept only one sequence from each 3 4 5 group of identical sequences, and used hierarchical clustering to group isolates based on 3 4 6 their pairwise distance and identified clusters of sequences that were within ≤ 1% of each 3 4 7
other, retaining a single sequence from each cluster for the analysis (retaining the sequence 3 4 8
with the lowest proportion of ambiguous sites). After stripping out these closely related 3 4 9
sequences, we generated a maximum-likelihood (ML) phylogenetic tree of the remaining 3 5 0 2839 sequences using RAxML (48), including 1000 bootstrap replicates (Fig. 1 ). We used 3 5 1 this tree to manually delineate sequences belonging to each genotype and excluded any 3 5 2 remaining recombinant sequences that had not been identified earlier in the process. 3 5 3 3 5 4
We aligned the sequences for each genotype separately, and generated ML phylogenetic 3 5 5
trees as previously described. We examined ML phylogenetic trees and generated bootstrap 3 5 6
values to define distinct clades containing ≥ 2 sequences with strong phylogenetic support 3 5 7
( Figures 2-9 ). Phylogenetic trees were examined in both traditional and radial layouts to 3 5 8 ensure that the subgenotypes and clades were being delineated accurately. We excluded 3 5 9
Genotype G from the phylogenetic analysis, as after removing highly similar sequences 3 6 0 there were just three sequences remaining. 3 6 1 3 6 2
Definition of new reference sequences 3 6 3
For each well-defined clade, we generated a consensus sequence and selected the closest 3 6 4 clinical isolate to the consensus sequence as the reference strain for that clade. We applied 3 6 5
a process of quality assurance to selection of reference strains as follows: 3 6 6
• We verified that isolates selected as reference strains were associated with an 3 6 7 associated publication indexed in PubMed; 3 6 8
• We checked that reference strains were genuine clinical isolates (rather than in silico 3 6 9
reconstructions such as consensus sequences); 3 7 0
• We rejected isolates that had insertions or deletions relative to the majority of 3 7 1 sequences in the clade; 3 7 2
• We avoided (where possible) sequences with many ambiguous sites; 3 7 3
• We avoided use of sequences containing known drug resistance mutations as 3 7 4 reference strains. Thus in the situation in which a sequence containing an rtM204 3 7 5 substitution in the 'YMDD' motif (associated with escape from lamivudine 3 7 6 therapy(49)) was initially selected as a reference sequence, we rejected this and 3 7 7
selected the next closest sequence to consensus. 3 7 8
• Three subgenotype references were selected with Hamming distances >50 relative 3 7 9
to the consensus sequence for the subgenotype clade (subgenotypes C4, C11 and 3 8 0 C_UA2). Alternative, more closely related sequences were often present within the 3 8 1 subgenotype clade but indels in the sequences and a lack of supportive publications 3 8 2 meant that other sequences were selected .  3  8  3   3  8  4 To define genotype reference sequences, we selected the reference sequence for the 3 8 5
subgenotype that contributed the largest number of sequences to that genotype (grey boxes, 3 8 6 Table 1 ). In cases where there were multiple clades for the subgenotype, we selected the 3 8 7
sequence from the largest clade as the reference. Where there was strong evidence to 3 8 8 support specific subgenotypes from both the literature and the phylogenetic analysis, we 3 8 9
included the subgenotype in the analysis. Where subgenotype designation was unclear, we 3 9 0
used BLAST to compare the sequence(s) to other sequences in online databases to see if 3 9 1 the subgenotype could be identified. We also examined trees to find the accession numbers 3 9 2 of subgenotypes that did not have an easily identifiable clade in the analysis using isolates 3 9 3 listed in Genbank. If they were not present, these subgenotypes were most likely removed 3 9 4
during the pairwise analysis for being highly similar to sequences already in the analysis, 3 9 5
suggesting further examination of their designation as a unique subgenotype may be 3 9 6
warranted. Where the subgenotype could not be identified, the clade was labelled 3 9 7 'unassigned'. 3 9 8 3 9 9
In situations in which we could not ascertain which subgenotype a clade belongs to, despite 4 0 0 examination of Genbank records and BLAST analysis of sequences, we have described 4 0 1 these as 'unassigned clades' (both in genotype C, Fig 4) . Identification of a Novel Hepatitis C Virus Genotype From Punjab, India: Expanding 5 2 0
Classification of Hepatitis C Virus Into 8 Genotypes. The Journal of Infectious 5 2 1
Diseases. 2018;(July):1-8. in each genotype analysed separately in Figures 2-9 . Maximum-likelihood phylogenetic 5 5 4
analysis of sequences used in this study after removing highly similar sequences, 5 5 5
demonstrating the strong genotypic clustering of the sequences. Bootstrap support ≥ 70 after 5 5 6
1000 replicates is given for the deepest branches on the tree. The scale bar indicates the 5 5 7 estimated nucleotide substitutions per site. *A strain known to be from a 14 th century 5 5 8 skeleton clustering distantly with genotype A, LT992441, was removed from the analysis. ** 5 5 9
KU736915 was identified as a genotype D/E recombinant and removed from the subsequent 5 6 0 analysis. and reference sequences for each clade indicated (red dots). Proposed reference strain for 5 6 5
the genotype, FJ692557 is highlighted with a blue dot. The subgenotype is given where it 5 6 6
could be reliably identified. Bootstrap support for branches ≥ 70 after 1000 replicates is 5 6 7
indicated. The scale bar indicates the estimated nucleotide substitutions per site. Previous 5 6 8
work has confirmed that there are at least 5 genotype A subgenotypes, although debate 5 6 9
continues about whether or not A3, A4 and A5 should all be considered 'quasi-subgenotype 5 7 0 A3' (9). Few sequences for subgenotypes *A4 (KM606737) and **A6 (GQ331046) were 5 7 1 retained in the study after pairwise analysis. The putative subgenotype A6 has previously 5 7 2
been identified in three African-Belgian patients (27). sequences. Well-defined clades have been highlighted with coloured dotted lines and 5 7 6
reference sequences for each clade indicated (red dots). Proposed reference strain for the 5 7 7 genotype, GU815637 is highlighted with a blue dot. The subgenotype is given where it could 5 7 8
be reliably identified. Bootstrap support for branches ≥ 70 after 1000 replicates is indicated. 5 7 9
The scale bar indicates the estimated nucleotide substitutions per site. An evaluation of the 5 8 0 genotype B phylogeny reclassified a number of putative subgenotypes as quasi-B3, with 5 8 1 debate continuing on whether or not this should also include B5 (50). sequences. Well-defined clades have been highlighted with coloured dotted lines and 5 8 5
reference sequences for each clade indicated (red dots). Proposed reference strain for the 5 8 6 genotype, GQ377617 is highlighted with a blue dot. The subgenotype is given where it could 5 8 7
be reliably identified. Bootstrap support for branches ≥ 70 after 1000 replicates is indicated. 5 8 8
The scale bar indicates the estimated nucleotide substitutions per site. We were unable to 5 8 9
verify the subgenotype of two genotype C clades, and these have been designated 5 9 0
unassigned clade 1 and 2 (unassigned_C (1) and unassigned_C (2), respectively). 5 9 1 5 9 2 Figure 5 ; Genomic-length maximum-likelihood phylogeny of HBV genotype D 5 9 3
sequences. Well-defined clades have been highlighted with coloured dotted lines and 5 9 4
reference sequences for each clade indicated (red dots). Proposed reference strain for the 5 9 5
genotype, KC875277is highlighted with a blue dot. The subgenotype is given where it could 5 9 6
be reliably identified. Bootstrap support for branches ≥ 70 after 1000 replicates is indicated. 5 9 7
The scale bar indicates the estimated nucleotide substitutions per site. Previous work has 5 9 8
indicated D3 and D6 strains cluster together and should be classed as a single subgenotype 5 9 9
(51). sequences. Well-defined clades have been highlighted with coloured dotted lines and 6 0 9
reference sequences for each clade indicated (red dots). Proposed reference strain for the 6 1 0 genotype, HM585194 is highlighted with a blue dot. The subgenotype is given where it could 6 1 1 be reliably identified. Bootstrap support
